Drug Approval | May 04, 2023
Indoco receives EIR for its Plant I manufacturing facility in Goa
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
The appointment is effective from May 01, 2023 for five years
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
The business and product range of Ipca and that of Unichem complements each others business and product range
The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Enabling wireless monitoring In ambulances and homes
Subscribe To Our Newsletter & Stay Updated
